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Abstract The double-stranded RNA-specific adenosine deami-
nases ADAR1 and ADAR2 convert adenosine (A) residues to
inosine (I) in messenger RNA precursors (pre-mRNA). Their
main physiological substrates are pre-mRNAs encoding subunits
of ionotropic glutamate receptors or serotonin receptors in the
brain. ADAR1 and ADAR2 have similar sequence features,
including double-stranded RNA binding domains (dsRBDs) and a
deaminase domain. The tRNA-specific adenosine deaminases
Tad1p and Tad2p/Tad3p modify A 37 in tRNA-Ala1 of
eukaryotes and the first nucleotide of the anticodon (A 34) of
several bacterial and eukaryotic tRNAs, respectively. Tad1p is
related to ADAR1 and ADAR2 throughout its sequence but
lacks dsRBDs. Tad1p could be the ancestor of ADAR1 and
ADAR2. The deaminase domains of ADAR1, ADAR2 and
Tad1p are very similar and resemble the active site domains of
cytosine/cytidine deaminases.
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1. Introduction
RNA editing can be de¢ned as cotranscriptional or post-
transcriptional RNA processing reactions other than capping,
splicing or 3P-end formation that change the nucleotide se-
quence of the RNA product. RNA editing reactions occur
in many organisms and operate by di¡erent molecular mech-
anisms. Major editing types are the insertion or deletion of
nucleotides and the substitution of bases by modi¢cation (for
reviews see [1,2]). Here we discuss the reactions that lead to
the conversion of adenosine (A) residues to inosine (I) in
mammalian messenger RNA precursors (pre-mRNA) and in
eukaryotic and prokaryotic tRNAs.
2. Double-stranded RNA-speci¢c adenosine deaminases and
pre-mRNA editing
Results accumulated in the last 10 years strongly suggest
that one type of pre-mRNA editing in mammals is catalyzed
by a group of enzymes originally called double-stranded
RNA-speci¢c adenosine deaminases (dsRAD) or DRADA
(for ds RNA adenosine deaminase; reviewed in [3]). More
recently, the enzymes have been renamed and are now called
ADARs, for adenosine deaminases that act on RNA [4].
ADARs catalyze the hydrolytic deamination at the C-6
atom of adenosine, thus converting the nucleoside within
the RNA chain to inosine (reviewed in [5^7]). In extended
double-stranded RNA (dsRNA) in vitro, any adenosine can
be deaminated unspeci¢cally, although with some preference
for C or U 5P to the target A [8]. Such ‘hypermutation type’ of
editing has also been observed in the RNAs encoding the
matrix protein of measles virus and other negative-strand vi-
ruses and in polyoma virus. Non-viral examples are pre-
mRNA of the Drosophila 4f-rnp gene, which encodes an
RNA binding protein of unknown function and in transcripts
encoding a voltage-dependent potassium channel in the squid
Loligo peali (reviewed in [5,7,9]).
Inosine base-pairs with cytidine during reverse transcription
when cDNA is made from an edited RNA. Thus, the editing
event will appear as a conversion of adenosine to guanosine
upon sequencing the cDNA. Since inosine is also read as
guanosine by the translation apparatus [10], A to I editing
in nuclear pre-mRNA can alter codon speci¢cities in the ma-
ture mRNA and lead to changes of single amino acids within
a protein. The ¢rst physiological substrates identi¢ed for this
site-selective mode of RNA editing were pre-mRNAs encod-
ing subunits of ionotropic glutamate-gated cation channels
(GluRs) in the mammalian brain [11] (reviewed in [12,13]).
Some of the resulting changes of amino acids alter the func-
tional properties of GluRs formed by the assembly of edited
and unedited subunits. The physiologically most important
editing event controls the Ca2 permeability of the AMPA-
type GluRs which mediate fast excitatory synaptic transmis-
sion in central neurons. This site, designated the Q/R (gluta-
mate/arginine) site according to the amino acid encoded by
the unedited and edited RNA, respectively, is nearly 100%
edited in mammalian AMPA receptor subunit GluR-B
mRNA. The Q/R site is located in the second membrane seg-
ment (M2) of the GluR-B subunit and editing results in re-
duced permeability to Ca2 ions of AMPA receptors contain-
ing this subunit. GluR-B pre-mRNA contains a second
editing site (the arginine/glycine or R/G site) at the beginning
of a small alternatively spliced exon that is located in front of
the fourth membrane segment (M4). The extent of R/G site
editing is regulated during the development of the mammalian
brain and editing controls the kinetic properties of the AMPA
receptor and leads to faster recovery rates from receptor de-
sensitization [13].
In ¢ve of the approximately 18 mRNAs encoding sequence-
related subunits for ionotropic GluRs, up to three codons per
transcript can be altered by adenosine deamination [12,13]. In
all cases investigated, this type of editing requires dsRNA
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structures, which are formed by intramolecular base-pairing
between exonic nucleotides around the editing site and a short
sequence that is complementary to the editing site, located in
the downstream intron and termed ECS for ‘editing site com-
plementary sequence’. Mutations in the ECS that prevent
base-pairing and thus change the structure of the RNA abol-
ish its potential to be edited [14]. Deletion of the ECS from
the nuclear gene leads to the complete loss of edited mRNA in
mice and causes an early lethal phenotype [15]. This shows
that the RNA structure is necessary for GluR-B pre-mRNA
editing and underscores the physiological importance of the
codon change at the Q/R site in vivo.
In addition to pre-mRNAs encoding GluRs other pre-
mRNA substrates have been identi¢ed which are site-selec-
tively edited by adenosine to inosine conversion. Examples
are serotonin receptor 5HT2C pre-mRNA in the brain [16])
and hepatitis delta virus (HDV) antigenomic RNA [17]. Sero-
tonin receptors transmit signals by coupling to G-proteins and
stimulation of phospholipase C. They have diverse functions,
including the regulation of synaptic transmission. Pre-mRNA
encoding the 5HT2C receptor subtype is edited at four major
sites within the second intracellular loop of the protein. Dif-
ferential editing generates seven receptor isoforms which di¡er
in their e⁄ciency of signal transduction. Editing in the HDV
antigenomic RNA converts a single adenosine residue to in-
osine and causes the change of a stop codon (UAG) to a
tryptophan codon (UIG) in the viral RNA encoding hepatitis
delta antigen. The shorter form of the protein participates in
the transcription of HDV RNA; the extended protein derived
from the edited RNA represses RNA replication and is in-
volved in packaging the viral RNA.
In vitro systems have been developed with which the site-
speci¢c editing of the AMPA receptor GluR-B pre-mRNA
could be reproduced by incubating synthetic RNA substrates
in nuclear extract from HeLa cells [18^20]. The Q/R site and
the R/G site of GluR-B pre-mRNA can be edited in vitro.
Moreover, analysis of mutant substrates, nucleotide analysis,
sequencing and mapping of fragments after nuclease digestion
showed that editing occurred by deamination of adenosine
residues and that in vitro editing depends on a double-
stranded RNA con¢guration around the editing sites. These
results suggested that the editing of GluR-B pre-mRNA
was catalyzed by dsRNA-speci¢c adenosine deaminase 1
(ADAR1), an enzyme that had been puri¢ed and cloned
from various sources [21^25]. Indeed, puri¢ed or recombinant
ADAR1 was able to speci¢cally edit certain sites in synthetic
pre-mRNAs. However, not all potential editing sites could be
converted by the enzyme [26]. For example, hADAR1 could
edit the R/G site of GluR-B pre-mRNA and the so-called
hotspot 1 site within the adjacent intron but was inactive on
substrates carrying the Q/R site. Fractionation of HeLa cell
nuclear extracts showed that hADAR1 could be separated
from a second activity which was able to edit the Q/R site
[27,28]. The second activity corresponds to the human homo-
logue of rat RED1 (RNA-speci¢c editase 1, now called hA-
DAR2 [29,30]). Like ADAR1, ADAR2 can also deaminate
the adenosine at the R/G site. Thus, the two enzymes have
distinct but overlapping substrate speci¢cities (Fig. 1, right
panel). In transfection experiments and in vitro, both
ADAR1 and ADAR2 are required to catalyze the editing of
the di¡erent sites in serotonin receptor pre-mRNA and of the
glutamate receptor subtypes GluR-C, GluR-D, GluR-5 and
GluR-6 [6,7].
3. Domain organization of ADARs
All ADARs consist of a single polypeptide with a modular
domain organization (Fig. 1, left panel). A variable N-termi-
nal region is followed by two or three dsRNA binding do-
mains (dsRBD). dsRBDs are structures found in many pro-
teins that interact with dsRNAs and are responsible for the
recognition of the secondary and tertiary structure of double-
Fig. 1. Protein domain structure of mammalian adenosine deaminases that act on RNA (ADARs) and the S. cerevisiae protein Tad1p/scA-
DAT1. ADAR1 and ADAR2 contain bipartite nuclear localization signals (NLS, dark blue), double-stranded RNAbinding domains (dsRBDs,
red) and a catalytic deaminase domain (green box). Human ADAR1 contains an RG-enriched domain (yellow box) and a duplication of 48
amino acids (marked by arrows). The two Z-DNA binding domains are indicated as light blue boxes. The size of the proteins is indicated at
the C-terminus by their number of amino acids. The aa sequence relation is indicated as percentage identity (Id) and similarity (S). The right
panel depicts the ability of the RNA deaminases to modify selected sites in diverse substrates in vitro.
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stranded regions within RNA molecules [31]. The active site is
represented by a deaminase domain containing three con-
served deaminase motifs [6,7]. The deaminase motifs are
distantly related to those of cytosine deaminase, cytidine/de-
oxycytidine deaminases and to the catalytic subunit (APO-
BEC-1) of the mammalian apolipoprotein B (apoB) mRNA
editing complex involved in C to U conversion [1,32] (see
below).
The extended N-terminal portion of ADAR1 contains a
potential nuclear localization signal and two Z-DNA binding
motifs [33], the function of which is not known. Human
ADAR1 has a perfect duplication of 48 amino acids and six
Arg/Gly repeats within a stretch of 40 amino acids [24]. This
RG-enriched domain may be a target for posttranslational
modi¢cation by arginine dimethylation and may mediate the
shuttling of the protein between the nucleus and the cyto-
plasm [34]. ADAR1 and ADAR2 occur as multiple isoforms
generated by alternative splicing. These variants di¡er in en-
zyme activity and in their preference for editing di¡erent sites
in pre-mRNA substrates (reviewed in [7]).
With the exception of RED2, which is expressed predom-
inantly in the brain and for which no RNA substrate has been
identi¢ed yet [35], ADARs are found in most mammalian
tissues [6,7]. For this reason, A to I-type editing of messenger
RNA precursors has been postulated to be a widespread phe-
nomenon and the existence of many other target pre-mRNAs
outside the central nervous system has been predicted. How-
ever, except for the few examples mentioned above, no addi-
tional physiological substrates have been found until now.
4. Adenosine deaminases acting on tRNA
The sequence information obtained from the cloning of
ADARs was used to search for homologous proteins in the
yeast genome and revealed an open reading frame (ORF) with
sequence homology to the deaminase motifs in the mamma-
lian RNA editing enzymes ADAR1 and ADAR2 [36] (Fig. 1).
The yeast sequence contains the three putative zinc-chelating
amino acids and a proton-transferring amino acid typical of
cytidine deaminases (see below). However, the predicted pro-
tein lacks dsRDBs that are hallmarks of ADARs acting in the
editing of messenger RNA precursors and on extended
dsRNA substrates. Accordingly, in vitro assays with yeast
extracts and dsRNA substrates did not reveal any such activ-
ity. Because modi¢cation of adenosine to inosine is also oc-
curring in some tRNAs, we considered tRNAs potential sub-
strates for the yeast enzyme. It is known that in all
eukaryotes, inosine is present at position 37 (3P adjacent to
the anticodon) of tRNA-Ala1 and at position 34 (the ¢rst base
of the anticodon) of seven or eight di¡erent tRNA species in
yeast and higher eukaryotes, respectively [37] (Fig. 2B). Ino-
sine at position 34 plays a crucial role in protein synthesis by
allowing alternative pairing with U, C, or A in the third
position of codons [38]. The physiological signi¢cance of in-
osine 37, which is present in some eukaryotic tRNA-Ala iso-
acceptors and is secondarily converted to N1-methylinosine by
a SAM-dependent methyltransferase [39] (H. Grosjean, per-
sonal communication), is not known.
We have cloned the candidate yeast gene, expressed and
puri¢ed the recombinant protein, and tested it with di¡erent
tRNA substrates [36]. The protein is indeed a tRNA modi¢-
cation enzyme, which speci¢cally deaminates adenosine 37 of
alanine tRNA. We named the enzyme scADAT1 (for S. cere-
visiae adenosine deaminase acting on tRNA 1) and its gene
TAD1, for tRNA adenosine deaminase 1.
Adenosine or inosine at position 34 is not required for the
modi¢cation of A 37 by Tad1p, as shown by testing mutant
tRNA-Ala where A 34 was changed to guanosine. Removing
one base from the anticodon loop abolished the reaction.
Mutations a¡ecting the three-dimensional structure of
Fig. 2. A: Modi¢cations in yeast tRNA-Ala. Adenosine at position 34 is converted to inosine by the tRNA-speci¢c adenosine deaminase Tad2/
Tad3 (yellow). Adenosine at position 37 is deaminated by Tad1p/ADAT1 (blue box) and further methylated to N1-methylinosine. B: S. cerevi-
siae and E. coli tRNAs containing inosine (yellow) at the wobble position of the anticodon (boxed).
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tRNA-Ala also prevent the formation of I 37 by Tad1p. Thus,
the reaction requires the correct folding of the tRNA and is
absolutely speci¢c for tRNA-Ala.
The TAD1 gene is not essential and a mutant strain (tad1-1)
grows as e⁄ciently as wild-type controls. The in vivo modi¢-
cation state of tRNA-Ala was monitored by RT-PCR ampli-
¢cation and sequence analysis. A 37 remained unmodi¢ed in
the mutant cells whereas A 34 was edited normally. These
results indicate that the modi¢cations of A 37 and of A 34
are catalyzed by two di¡erent enzymes and that the activity
converting A 34 to I 34 is not a¡ected by the disruption of the
TAD1 gene.
A search of the yeast genome for the presence of an ORF
related to TAD1 revealed two additional yeast genes and their
protein products (termed TAD2/scADAT2 and TAD3/scA-
DAT3) that are distantly related to Tad1p (A. Gerber and
W. Keller, unpublished results). Tad2p and Tad3p form a
two-subunit heteromeric enzyme which speci¢cally deaminates
A 34 to I 34 in the wobble position of several tRNAs. In
contrast to the TAD1 gene, both TAD2 and TAD3 are essen-
tial genes. This underscores the importance of the inosine in
the anticodon of the a¡ected tRNAs to function as wobble
base in codon-anticodon pairing.
We have recently also identi¢ed homologues of TAD2 in
Escherichia coli and in the human genome (J. Wolf, A. Gerber
and W. Keller, unpublished results). E. coli Tad2p is involved
in deaminating adenosine at position 34 of tRNA-Arg2, the
only bacterial tRNA containing inosine [39,40].
Fig. 3. Multiple sequence alignment of members of the ADAR family, scADAT1 and the putative S. pombe homolog spADAT1. Conserved
amino acids (s 60%) occurring in both types of enzymes are depicted within a black frame, similar amino acids which are conserved in at least
four proteins are boxed in gray. Amino acids only conserved in ADARs are boxed light red and residues conserved in ADATs/Tad1p are
marked blue. The deaminase domain (boxed) is characterized by conserved motifs (underlined) containing three putative Zn2-chelating residues
(yellow) and a proton-transferring amino acid (red). The alignment was generated with the GCG software programs LINEUP (manual align-
ment) and PILEUP (computer alignment) with a gap weight of 3.0 [44]. The carboxy-terminal parts of yeast Tad1ps were further aligned man-
ually to the other three sequences.
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5. Tad1p, an ancestor of ADARs?
Tad1p is 22% identical and 46% similar to the C-terminal
part of mammalian ADARs Fig. 1). Surprisingly, the se-
quence homology between Tad1p and ADAR1/2 extends
through the entire protein sequence of Tad1p (Fig. 3) and is
not limited to the characteristic deaminase domain found in
all ADAR enzymes (see below). This suggests that the two
classes of proteins, the mammalian pre-mRNA editing en-
zymes and the yeast tRNA modi¢cation enzyme, did not ob-
tain catalytic capacity by independent evolution of a similar
catalytic center, but more likely, the enzymes are directly re-
lated to each other. Because Tad1p has no dsRBD or any
other recognizable RNA binding motif, it must recognize its
tRNA substrate by some other means. Perhaps, the enzyme
binds to RNA via residues localized within its deaminase do-
main in a manner similar to APOBEC-1 [41]). The sequence
conservation between Tad1p and the mammalian RNA edit-
ing enzymes ADAR1 and ADAR2 and the similarities in their
biochemical properties suggest a possible evolutionary rela-
tionship between the two classes of enzymes. Whereas the
ADAR1 proteins contain three and ADAR2 and RED2 two
dsRBDs, only one dsRBD was predicted for putative deami-
nases from Caenorhabditis elegans. The di¡erent numbers of
dsRBDs may re£ect a progressive acquisition of dsRBDs in
the amino-terminal region upstream of the deaminase domain
during evolution. In this scenario, the ancestral gene did
not have dsRBDs, as is the case for the yeast gene TAD1.
Alternatively, it is possible that Tad1p has lost its dsRBDs
during evolution to gain the new function of a tRNA-speci¢c
adenosine deaminase. We favor the ¢rst scenario in which
the dsRBD building blocks may have fused to the amino-
terminus of an ancestral gene after the animal/fungal diver-
gence.
The common ancestor of the deaminase domain of Tad1p
and the other members of the ADAR family is not known.
TAD1 represents the only gene in the genomes of Saccharo-
myces cerevisiae and Schizosaccharomyces pombe containing
an ADAR-like deaminase domain. In contrast, no ADAR-
related domain is present in the genome of E. coli K-12
[42]. This correlates with the observation that I 37 is only
found in tRNA-Ala of eukaryotes.
6. Relationships between deaminase domains
The active site domains of enzymes catalyzing base conver-
sions by hydrolytic deamination are shown in Fig. 4. As has
been pointed out before [1,6,22,24,32,43], ADARs have a de-
aminase domain that resembles that of other nucleoside/nu-
cleotide deaminases, including the active site domain of the
subunit (APOBEC-1) which converts C to U in mammalian
apolipoprotein B pre-mRNA. Remarkably, all of these en-
zymes show little resemblance to adenosine deaminases
(ADAs, Fig. 4, bottom). Instead, they share distinctive se-
quence signatures containing three key amino acids (His,
Cys, Cys) involved in zinc coordination (marked yellow in
Fig. 4) and a glutamine known to be responsible for transition
state stabilization and proton shuttling in the prototype en-
zyme cytidine deaminase of E. coli (ECCD; marked red in
Fig. 4). These critical residues are embedded within short
conserved sequence motifs (designated I, II and III in Fig. 4).
The deaminase domains of ADARs and Tad1p di¡er from
the other proteins in the deaminase family by an extended
spacing between the second and third cysteine. In addition,
Fig. 4. Multiple sequence alignment of deaminase domains. Putative Zn2-chelating residues are yellow. Acidic amino acids are boxed in red,
basic ones are in purple, hydrophilic in green, hydrophobic in blue, aromatic in light blue, the neutral glycine is brown. The highly conserved
ADAR-like deaminase motifs I, II and III are overlined. The GenBank accession numbers are indicated in a column next to the names of the
enzymes.
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the third cysteine of ADARs and Tad1p is surrounded by
four highly conserved amino acids (motif III).
Comparison of the sequence organization of the newly dis-
covered tRNA-speci¢c adenosine deminases Tad2p and
Tad3p with the other modifying enzymes will hopefully help
to understand how the diverse proteins of the deaminase fam-
ily have evolved.
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